Entrada Therapeutics Inc (TRDA)
18.05
+0.12
(+0.67%)
USD |
NASDAQ |
Nov 21, 16:00
18.08
+0.02
(+0.14%)
After-Hours: 20:00
Entrada Therapeutics Market Cap: 676.37M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 670.94M |
| November 19, 2024 | 664.95M |
| November 18, 2024 | 652.98M |
| November 15, 2024 | 667.95M |
| November 14, 2024 | 712.48M |
| November 13, 2024 | 746.90M |
| November 12, 2024 | 740.54M |
| November 11, 2024 | 744.28M |
| November 08, 2024 | 741.66M |
| November 07, 2024 | 719.59M |
| November 06, 2024 | 698.26M |
| November 05, 2024 | 696.76M |
| November 04, 2024 | 664.95M |
| November 01, 2024 | 658.59M |
| October 31, 2024 | 641.38M |
| October 30, 2024 | 644.41M |
| October 29, 2024 | 646.28M |
| October 28, 2024 | 649.65M |
| October 25, 2024 | 635.43M |
| October 24, 2024 | 629.82M |
| October 23, 2024 | 634.69M |
| October 22, 2024 | 640.67M |
| October 21, 2024 | 647.78M |
| October 18, 2024 | 652.26M |
| October 17, 2024 | 659.37M |
| Date | Value |
|---|---|
| October 16, 2024 | 660.49M |
| October 15, 2024 | 655.63M |
| October 14, 2024 | 666.85M |
| October 11, 2024 | 627.58M |
| October 10, 2024 | 591.30M |
| October 09, 2024 | 604.77M |
| October 08, 2024 | 612.99M |
| October 07, 2024 | 618.60M |
| October 04, 2024 | 638.43M |
| October 03, 2024 | 614.86M |
| October 02, 2024 | 609.25M |
| October 01, 2024 | 598.41M |
| September 30, 2024 | 597.66M |
| September 27, 2024 | 611.93M |
| September 26, 2024 | 586.64M |
| September 25, 2024 | 559.85M |
| September 24, 2024 | 572.87M |
| September 23, 2024 | 542.00M |
| September 20, 2024 | 546.09M |
| September 19, 2024 | 557.99M |
| September 18, 2024 | 507.77M |
| September 17, 2024 | 526.75M |
| September 16, 2024 | 541.25M |
| September 13, 2024 | 557.99M |
| September 12, 2024 | 552.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
172.20M
Minimum
May 09 2022
1.094B
Maximum
Nov 17 2021
479.73M
Average
479.04M
Median
May 14 2024
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 2.520B |
| Vertex Pharmaceuticals Inc | 115.99B |
| Assembly Biosciences Inc | 94.01M |
| Sarepta Therapeutics Inc | 10.55B |
| Regenxbio Inc | 456.31M |
Market Cap Related Metrics
| PE Ratio | 11.37 |
| PS Ratio | 3.030 |
| Price to Book Value | 1.601 |
| Price | 18.05 |
| Earnings Yield | 8.80% |
| Operating PE Ratio | 11.28 |
| Normalized PE Ratio | 11.37 |